TRIVTRON HEALTHCARE PRIVATE LIMITED

Chennai-based Trivitron +ealthcare generated a revenue of Rs 469 crore during the FY 20-21 marking a 2x growth in its business, in comparison to the revenue figure of Rs 206 crore generated in the previous fiscal. The year 2020 saw the company launching a range of hand sanitisers and protective coverall for the healthcare professionals when the pandemic started. Trivitron +ealthcare literally changed the gears with a single motto to create solutions in its relentless fight against the COVID-19 pandemic. The new .iran +ealth Shield range of hand sanitisers and personal protective coveralls is the result of the same. Around the same time, the company announced the appointment of Rajesh Patel as Chief Executive Officer of In-Vitro Diagnostics, India business. Patel is an experienced professional with around 29 years in the areas of sales, marketing business development in the healthcare segment. +e has held a leadership role in global and Indian healthcare companies and has a rich and diverse experience in pharmaceuticals, clinical research, and IVD medical devices segment. Trivitron also entered into collaboration with 8S-based Anatomage Inc, a market leader in 3D medical virtualisation technology, to distribute virtual anatomy dissection table for medical education for scholars, researchers, medical and healthcare students in south and west regions in India. The Anatomage virtual anatomy dissection table offers strategic advantage when it comes to medical education and anatomical studies offering advanced and unique anatomy content to users for educational and training purposes. In its fight against COVID-19, the company launched a full suite of indigenously developed testing products, as the organisation’s contribution towards Atmanirbhar Bharat. For instance, Indian Council of Medical Research (ICMR) approved ‘Biocard Pro COVID-19 Rapid Antigen’ was developed to provide accurate results in just 7-10 minutes. The rapid antigen kit is a chromatographic immunoassay for the qualitative detection of COVID-19 specific antigen present in human nasopharyngeal. Trivitron +ealthcare also started developing a comprehensive range of ICMR approved COVID-19 solutions including RT-PCR Tests (COVIDsure COVIDsure Pro), RNA Extraction kits (RNAsure), Viral Transport Media (ViSure), Total Antibody ELISA Test (COVIDscreen Plus) and ELISA Ig* (COVID .avach Ig*) testing kits for COVID-19. Trivitron +ealthcare has multiple brands associated with it namely .iran Medical systems, Labsystems Diagnostics, Trivitron +ealthcare Middle East, Trivitron +ealthcare Africa and Bome Trivitron. The organisation has been working to make quality healthcare affordable and is among the pioneers in making high-end medical technology accessible, making use of its broad network of channel partners, and associates. Over the years, the company has been acclaimed for its high-value products and engineering support across various healthcare verticals ranging from radiation protection, imaging, newborn screening, in-vitro diagnostics, infectious diseases and a lot more.